Switzerland
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • DK
    • PL
    • UK
  • Switzerland
    • Basel
    • Bern
    • Geneva
    • Lausanne
    • Zürich
  • Schweiz
  • Suisse
  • Alps
  • Business
    • ABB
    • Chubb
    • Glencore
    • Nestlé
    • Novartis
    • Roche
    • UBS
    • Vitol
    • Zurich Insurance
  • NATO
  • US
  • Africa
  • Afrique

Categories

  • ABB
  • Alps
  • Basel
  • Bern
  • Chubb
  • Geneva
  • Glencore
  • Lausanne
  • Nestlé
  • Novartis
  • Roche
  • Switzerland
  • UBS
  • Vitol
  • Zürich
  • Zurich Insurance
Switzerland
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • DK
    • PL
    • UK
  • Switzerland
    • Basel
    • Bern
    • Geneva
    • Lausanne
    • Zürich
  • Schweiz
  • Suisse
  • Alps
  • Business
    • ABB
    • Chubb
    • Glencore
    • Nestlé
    • Novartis
    • Roche
    • UBS
    • Vitol
    • Zurich Insurance
  • NATO
  • US
  • Africa
  • Afrique

Browsing Tag

fair value

75 posts
RRoche
Will The Market Correct The Share Price In The Future?
Read More

Roche Holding (SWX:ROG) Valuation Check After Key FDA And Phase III Milestones

  • 2026-02-27
Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million…
GGlencore
A Look At Glencore (LSE:GLEN) Valuation After Recent Mixed Short Term Share Price Moves
Read More

Is It Too Late To Consider Glencore (LSE:GLEN) After A 71% One-Year Rally?

  • 2026-02-27
Make better investment decisions with Simply Wall St’s easy, visual tools that give you a competitive edge. If…
UUBS
Should UBS’s Upgrade and Deal Talks Prompt a Rethink of BlackRock’s (BLK) Evolving Profit Engine?
Read More

Should UBS’s Upgrade and Deal Talks Prompt a Rethink of BlackRock’s (BLK) Evolving Profit Engine?

  • 2026-02-26
Over the past week, BlackRock has featured in multiple developments, including an analyst upgrade at UBS, insider share…
NNovartis
Assessing Novartis (SWX:NOVN) Valuation After Positive Phase III Data And Upcoming Regulatory Milestones
Read More

Assessing Novartis (SWX:NOVN) Valuation After Positive Phase III Data And Upcoming Regulatory Milestones

  • 2026-02-25
Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply…
CChubb
Facts to Know Before Betting on It
Read More

Facts to Know Before Betting on It

  • 2026-02-24
Chubb (CB) has recently been on Zacks.com’s list of the most searched stocks. Therefore, you might want to…
AABB
ABB Taps Automation Extended And AI Data Centers For Growth
Read More

Is ABB (SWX:ABBN) Still Attractively Priced After Its Strong Multi Year Share Price Run

  • 2026-02-23
Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St’s investing ideas for…
AABB
ABB Taps Automation Extended And AI Data Centers For Growth
Read More

Assessing ABB (SWX:ABBN) Valuation After Strong Recent Share Price Momentum

  • 2026-02-21
Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply…
UUBS
What Veracyte (VCYT)'s UBS Rating Reaffirmation and 2026 Outlook Means For Shareholders
Read More

What Veracyte (VCYT)’s UBS Rating Reaffirmation and 2026 Outlook Means For Shareholders

  • 2026-02-19
UBS recently reaffirmed its Buy rating on Veracyte after the company’s fourth-quarter testing revenue came in ahead of…
RRoche
Is It Time To Reassess Roche Holding (SWX:ROG) After Its Strong Multi Year Share Price Run?
Read More

Looking at the Narrative for Roche After New Trial Results and Strategic Shifts

  • 2026-02-19
Roche Holding’s fair value estimate has edged up to about CHF 312 from roughly CHF 305, supported by…
RRoche
Is It Time To Reassess Roche Holding (SWX:ROG) After Its Strong Multi Year Share Price Run?
Read More

Assessing Valuation After Recent Quiet Uptrend in Share Price

  • 2026-02-18
If you have been watching Roche Holding (SWX:ROG), you might be wondering what to make of its recent…
RRoche
Is It Time To Reassess Roche Holding (SWX:ROG) After Its Strong Multi Year Share Price Run?
Read More

How the Narrative Around Roche Is Evolving Amid Analyst Updates and Clinical Shifts

  • 2026-02-17
Roche Holding’s fair value estimate has seen a modest increase, with the latest target rising from CHF 298.64…
RRoche
Is It Time To Reassess Roche Holding (SWX:ROG) After Its Strong Multi Year Share Price Run?
Read More

Is FDA’s Fast Subcutaneous Lunsumio VELO Approval Reshaping the Investment Case For Roche (SWX:ROG)?

  • 2026-02-17
In December 2025, Genentech, part of the Roche Group, received U.S. FDA accelerated approval for Lunsumio VELO, a…
Switzerland
www.europesays.com